In the current study, we demonstrated that AGR2 coexpresses with CTSB/CTSD in NPC cells and tissues, and that downregulation of AGR2 by siRNA results in the reduction of the CTSB/CTSD expression in 6–10B cells with DNP treatment. The gene discussed is CTSD; the disease is nasopharyngeal carcinoma.